HK1103075A1 - 2-(1h-indolylsulfanyl)-benzyl amine derivatives as ssri - Google Patents

2-(1h-indolylsulfanyl)-benzyl amine derivatives as ssri

Info

Publication number
HK1103075A1
HK1103075A1 HK07107553.7A HK07107553A HK1103075A1 HK 1103075 A1 HK1103075 A1 HK 1103075A1 HK 07107553 A HK07107553 A HK 07107553A HK 1103075 A1 HK1103075 A1 HK 1103075A1
Authority
HK
Hong Kong
Prior art keywords
indolylsulfanyl
ssri
amine derivatives
benzyl amine
benzyl
Prior art date
Application number
HK07107553.7A
Other languages
English (en)
Inventor
Jan Kehler
Karsten Juhl
Jimmy Sejberg
Morten Bang Noergaard
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/DK2004/000894 external-priority patent/WO2005061455A1/en
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of HK1103075A1 publication Critical patent/HK1103075A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK07107553.7A 2003-12-23 2007-07-13 2-(1h-indolylsulfanyl)-benzyl amine derivatives as ssri HK1103075A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200301923 2003-12-23
PCT/DK2004/000894 WO2005061455A1 (en) 2003-12-23 2004-12-21 2-(1h-indolylsulfanyl)-benzyl amine derivatives as ssri

Publications (1)

Publication Number Publication Date
HK1103075A1 true HK1103075A1 (en) 2007-12-14

Family

ID=36603121

Family Applications (1)

Application Number Title Priority Date Filing Date
HK07107553.7A HK1103075A1 (en) 2003-12-23 2007-07-13 2-(1h-indolylsulfanyl)-benzyl amine derivatives as ssri

Country Status (24)

Country Link
EP (1) EP1860100B1 (xx)
KR (2) KR20080092471A (xx)
CN (2) CN101372474A (xx)
AR (1) AR046978A1 (xx)
AT (1) ATE500220T1 (xx)
CA (1) CA2551168C (xx)
DE (1) DE602004031680D1 (xx)
DK (1) DK1860100T3 (xx)
EA (2) EA010666B1 (xx)
ES (1) ES2362237T3 (xx)
HK (1) HK1103075A1 (xx)
IS (2) IS2551B (xx)
ME (1) ME01040B (xx)
MY (1) MY143038A (xx)
NO (1) NO336676B1 (xx)
NZ (1) NZ547046A (xx)
PL (1) PL1860100T4 (xx)
PT (1) PT1860100E (xx)
RS (1) RS51899B (xx)
SG (1) SG141463A1 (xx)
SI (1) SI1860100T1 (xx)
TW (1) TWI347183B (xx)
UA (1) UA82920C2 (xx)
ZA (1) ZA200705870B (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101224201B (zh) * 2007-01-18 2011-10-05 和泓生物技术(上海)有限公司 多巴胺转运蛋白和去甲肾上腺素转运蛋白双重抑制剂的应用
ES2646834T3 (es) * 2010-08-20 2017-12-18 Amira Pharmaceuticals, Inc. Inhibidores de autotaxina y usos de los mismos

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3803143A (en) 1969-09-08 1974-04-09 Eisai Co Ltd 6-amino alkylene 6,7-dihydro-5h-dibenzo (b,g),(1,5)thiazocines
US4018830A (en) 1969-09-22 1977-04-19 Merck & Co., Inc. Phenylthioaralkylamines
US4055665A (en) 1974-11-25 1977-10-25 Merck & Co., Inc. Treating arrythmia with phenylthioaralkylamines
US4056632A (en) 1975-07-21 1977-11-01 Burroughs Wellcome Co. 2-Hydroxymethyl-2'-aminomethyl-diphenylsulfides and method of use
EP0396827A1 (en) 1989-05-09 1990-11-14 SPOFA Spojené Podniky Pro Zdravotnickou Vyrobu 2-Phenylthiobenzylamine dervivatives and acid addition salts thereof
GB8912971D0 (en) 1989-06-06 1989-07-26 Wellcome Found Halogen substituted diphenylsulfides
GB9126311D0 (en) 1991-12-11 1992-02-12 Wellcome Found Substituted diphenylsulfides
CZ293595A3 (cs) 1995-11-09 1999-12-15 Farmak A. S. Deriváty N,N-dimethyl-2-(arylthio)benzylaminu, jejich soli, způsoby jejich přípravy a jejich použití v léčivých přípravcích
US5912256A (en) * 1996-06-20 1999-06-15 Eli Lilly And Company Compounds having effects on serotonin-related systems
DK0923548T3 (da) * 1996-08-27 2003-06-23 Wyeth Corp 4-Aminoethoxyindoler som dopamin-D2-agonister og som 5HT 1A-ligander
CA2372481A1 (en) 1999-04-30 2000-11-09 The Trustees Of The University Of Pennsylvania Spect imaging agents for serotonin transporters
US6410736B1 (en) 1999-11-29 2002-06-25 Pfizer Inc. Biaryl ether derivatives useful as monoamine reuptake inhibitors
US6436938B1 (en) 2001-01-22 2002-08-20 Pfizer Inc. Combination treatment for depression

Also Published As

Publication number Publication date
PL1860100T4 (pl) 2011-09-30
MY143038A (en) 2011-02-28
IS2551B (is) 2009-10-15
IS8827A (is) 2009-06-05
NZ547046A (en) 2010-04-30
TWI347183B (en) 2011-08-21
IS8467A (is) 2006-05-15
EA200702258A1 (ru) 2008-02-28
CA2551168C (en) 2011-09-13
UA82920C2 (en) 2008-05-26
RS51899B (en) 2012-02-29
ME01040B (me) 2010-05-07
NO336676B1 (no) 2015-10-19
TW200607499A (en) 2006-03-01
DK1860100T3 (da) 2011-06-14
EA200601226A1 (ru) 2006-10-27
CN100591666C (zh) 2010-02-24
SI1860100T1 (sl) 2011-06-30
ZA200705870B (en) 2009-09-30
EP1860100B1 (en) 2011-03-02
KR20080092471A (ko) 2008-10-15
EA010666B1 (ru) 2008-10-30
EP1860100A2 (en) 2007-11-28
CN101372474A (zh) 2009-02-25
EP1860100A3 (en) 2007-12-05
CN1898204A (zh) 2007-01-17
NO20063405L (no) 2006-07-24
IS2815B (is) 2012-11-15
PT1860100E (pt) 2011-05-25
AR046978A1 (es) 2006-01-04
DE602004031680D1 (de) 2011-04-14
KR20060118529A (ko) 2006-11-23
EA012752B1 (ru) 2009-12-30
KR100872022B1 (ko) 2008-12-05
ES2362237T3 (es) 2011-06-30
ATE500220T1 (de) 2011-03-15
SG141463A1 (en) 2008-04-28
CA2551168A1 (en) 2005-07-07
PL1860100T3 (pl) 2011-07-29

Similar Documents

Publication Publication Date Title
IL204829A0 (en) Aniline derivatives
IL183133A0 (en) Dibenzyl amine compounds and derivatives
IL211894A0 (en) Amide derivatives
ZA200702125B (en) Substituted aniline derivatives
IL175065A0 (en) Amide derivatives
IL174375A0 (en) Novel heterocyclic compounds as hsp90-inhibitors
IL209082A0 (en) Fushed heterocyclic compounds
IL169905A0 (en) Novel 2-pyridinecarboxamide derivatives
IL183657A0 (en) Amide derivatives
HK1093061A1 (en) Aminoalkanol derivatives
IL177204A0 (en) Novel 4-benzimidazol -2-ylpyridazin -3- one derivatives
IL181897A0 (en) Cyclic amine derivative or salt thereof
IL188064A0 (en) 2-(1h-indolylsulfanyl)-aryl amine derivatives
SI1652843T1 (sl) Amidni derivati
ZA200700162B (en) Novel heterocyclic compounds
IL182811A0 (en) Novel dicarboxamide derivatives
GB0329572D0 (en) Amide derivatives
HK1103075A1 (en) 2-(1h-indolylsulfanyl)-benzyl amine derivatives as ssri
GB0312368D0 (en) Novel ureido- and amido-pyrazolone derivatives
PL377766A1 (pl) Nowe sole związków o działaniu przeciw-drgawkowym
EP1538142A4 (en) AMINE DERIVATIVE
ZA200704149B (en) Dibenzyl amine compounds and derivatives
ZA200705150B (en) Amide derivatives
GB0409804D0 (en) Amide derivatives
GB0409800D0 (en) Amide derivatives

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20191221